advanced search

EXPERT VIEW

HOW CONNECTIVITY WILL REMODEL HEALTHCARE
EXPERT VIEW
Dr Marjorie Villien
HOW CONNECTIVITY WILL REMODEL HEALTHCARE
Marjorie Villien and Jerôme Mouly provide a forecast of the place of connectivity in the healthcare market and the significant changes it is likely to bring to both devices and the market itself.
THE PROMISE OF VOICE: CONNECTING DRUG DELIVERY THROUGH VOICE-ACTIVATED TECHNOLOGY
EXPERT VIEW
Chris Franzese
THE PROMISE OF VOICE: CONNECTING DRUG DELIVERY THROUGH VOICE-ACTIVATED TECHNOLOGY
Chris Franzese and Marty Coyne discuss the vast potential that voice-activated technologies, such as Amazon’s Alexa, have in the healthcare market. Running through the challenges posed by data security and human factors, they go on to explain how the rewards voice-activation offers are well worth the effort, spanning the drug delivery experience.
ENERGY HARVESTING: POWERING CONNECTED DRUG DELIVERY DEVICES
EXPERT VIEW
Charlotte Harvey
ENERGY HARVESTING: POWERING CONNECTED DRUG DELIVERY DEVICES
Charlotte Harvey examines the opportunities and practicalities of using energy harvesting technologies in drug delivery devices. With a specific focus on enabling connectivity functionality, Ms Harvey runs through the various aspects of energy harvesting and offers insight on whether it is the right choice for a new device development.
THE LATEST DIGITAL TOOLS REVEAL ACTUAL PATIENT BEHAVIOUR
EXPERT VIEW
Ryan Noble
THE LATEST DIGITAL TOOLS REVEAL ACTUAL PATIENT BEHAVIOUR
Ryan Noble and Tom Lawrie-Fussey discuss the potential of digital innovations to improve understanding of real patient behaviour and consequently increase adherence.
KEY CONSIDERATIONS FOR NON-CLINICAL SAFETY ASSESSMENT OF INHALED BIOPHARMACEUTICALS
EXPERT VIEW
Dr Simon Moore
KEY CONSIDERATIONS FOR NON-CLINICAL SAFETY ASSESSMENT OF INHALED BIOPHARMACEUTICALS
Simon Moore, Kirsty Haprer and Sylwia Marshall highlight some of the key considerations for the development of inhaled biopharmaceuticals, including non-clinical safety assessment.
DOES THE NEW EU MDR SPELL THE END OF GRANDFATHERING?
EXPERT VIEW
Helen Simmons
DOES THE NEW EU MDR SPELL THE END OF GRANDFATHERING?
Helen Simons and Stephanie Ward describe how the new EU Medical Devices Regulation will impact on “grandfathered” devices that were approved under old regulation and are currently on the market, but do not necessarily comply with current/updated regulatory standards, and explain the potential implications for device manufacturers.
DESIGN VALIDATION TESTING – DRUG DELIVERY DEVICES
EXPERT VIEW
Mark Turner
DESIGN VALIDATION TESTING – DRUG DELIVERY DEVICES
From a regulatory perspective, Mark Turner provides a summary of the current requirements of parenteral device manufacturers in the area of design validation testing.
EVALUATING A NEW MICROSPHERE BASED CONTROLLED-RELEASE DELIVERY SYSTEM
EXPERT VIEW
Dr S Mohan Mohanraj
EVALUATING A NEW MICROSPHERE BASED CONTROLLED-RELEASE DELIVERY SYSTEM
S Mohan Mohanraj and Meir Kende discuss the development of a microsphere based delivery system for an orally administered anthrax vaccine.
TECHNOLOGIES & CLINICAL STUDIES FOR THE ORAL DELIVERY OF CALCITONIN
EXPERT VIEW
Dr Nozer Mehta
TECHNOLOGIES & CLINICAL STUDIES FOR THE ORAL DELIVERY OF CALCITONIN
Nozer Mehta, James P Gilligan and William Stern summarise the different technologies that have been in development for oral delivery of peptides through the gastro-intestinal mucosal surfaces via the transcellular or the paracellular pathways and describe the results of several long-term clinical studies on the oral delivery of salmon calcitonin.
CONNECTED COMBINATION PRODUCTS: US ANALYSIS WITH POTENTIAL IMPLICATIONS WORLDWIDE
EXPERT VIEW
Napoleon Monroe
CONNECTED COMBINATION PRODUCTS: US ANALYSIS WITH POTENTIAL IMPLICATIONS WORLDWIDE
Napoleon Monroe provides an overview of the current status of connected combination products from the US perspective, with an emphasis on human factors, automated identity and regulation.
IMPLANTS CONNECT PATIENTS FOR BETTER, FASTER, MORE PERSONALISED CARE
EXPERT VIEW
Will Rosellini
IMPLANTS CONNECT PATIENTS FOR BETTER, FASTER, MORE PERSONALISED CARE
Will Rosellini and Beth Rosellini describe the rapidly advancing area of local field potential recording of nervous system activity which has the ability to record patient data directly and has the potential to form highly advanced connected and closed-loop systems.
THE POTENTIAL OF CONNECTED DEVICES FOR TACKLING ASTHMA
EXPERT VIEW
Garth Sutherland
THE POTENTIAL OF CONNECTED DEVICES FOR TACKLING ASTHMA
Garth Sutherland and Jon-Paul Sherlock explain how a strategic partnership between pharmaceutical companies and digital health companies can achieve improved outcomes through joint initiatives.
SPECIALTY PHARMA: HOW PRESCRIBING TECHNOLOGY AFFECTS TREATMENT OUTCOMES
EXPERT VIEW
Dr Amy Seung
SPECIALTY PHARMA: HOW PRESCRIBING TECHNOLOGY AFFECTS TREATMENT OUTCOMES
New solutions are now available which streamline the Electronic Health Record workflows and automate difficult areas to aid in the problem of patient non-adherence, particularly in the specialty drug sector. Amy Seung explains how they can work.
HOW CONTEXT & CONNECTIVITY CONTRIBUTE TO A FULL PICTURE OF HEALTH
EXPERT VIEW
Erika Vázquez
HOW CONTEXT & CONNECTIVITY CONTRIBUTE TO A FULL PICTURE OF HEALTH
Erika Vazquez shows how recent technological advances make it possible to gather detailed contextual data about patients and gain true insights into whether their treatments are genuinely improving their quality of life.
NEW TECHNOLOGIES FOR LOW-COST CONNECTED DRUG DELIVERY DEVICES
EXPERT VIEW
Dr Charley Henderson
NEW TECHNOLOGIES FOR LOW-COST CONNECTED DRUG DELIVERY DEVICES
Charley Henderson provides an overview of the various wireless connectivity options that are now available for devices and looks at how the corresponding electronic system costs can be reduced to drive widespread adoption.
NEEDLE-FREE JET INJECTION IN WORKPLACE INFLUENZA CLINICS
EXPERT VIEW
Tara Miller
NEEDLE-FREE JET INJECTION IN WORKPLACE INFLUENZA CLINICS
Tara Miller, Chris Galloway, and William E Gannon Jr evaluate an unmet need for increasing immunisation coverage in workplace influenza clinics by offering needle-free injection technology.
INJECTABLE DRUG DELIVERY: DEVICES MEET NEXT-GENERATION FORMULATIONS
EXPERT VIEW
Dr Iulia Karlsson
INJECTABLE DRUG DELIVERY: DEVICES MEET NEXT-GENERATION FORMULATIONS
Iulia Karlsson, discusses a new technology called BeloGal which allows drugs to be delivered in high doses to the right organ and avoids the problems of low water solubility that hamper many modern formulations.
AUTO-INJECTOR DESIGN: MANAGING DRUG TEMPERATURE VARIATIONS
EXPERT VIEW
Jake Cowperthwaite
AUTO-INJECTOR DESIGN: MANAGING DRUG TEMPERATURE VARIATIONS
Jake Cowperthwaite examines the impact of environmental and drug temperature variation on auto-injector performance and describes techniques for managing this variation on modern auto-injectors.
INNOVATIVE NASAL APPLICATION REQUIRES INNOVATIVE FILLING TECHNOLOGY
EXPERT VIEW
Dr Karlheinz Seyfang
INNOVATIVE NASAL APPLICATION REQUIRES INNOVATIVE FILLING TECHNOLOGY
Karlheinz Seyfang discusses the development of a system for the nasal delivery of a thixotropic gel formulation, from the design of the system through to the production line.
CONTROLLED-RELEASE SYSTEMS FOR PROTEINS & PEPTIDES
EXPERT VIEW
Dr S Mohan Mohanraj
CONTROLLED-RELEASE SYSTEMS FOR PROTEINS & PEPTIDES
S Mohan Mohanraj and Meier Kende discuss development of a viable intranasal microsphere-based delivery system and how it delivers a recombinant anthrax vaccine via two-dose immunisation.
ASSURE INHALER SAFETY & PERFORMANCE: POLYMERS, COLOUR & ADDITIVES
EXPERT VIEW
Stephen Duckworth
ASSURE INHALER SAFETY & PERFORMANCE: POLYMERS, COLOUR & ADDITIVES
Stephen J Duckworth describes some of the application of polymer colourants and additives in respiratory drug delivery devices, highlighting the strict regulatory environment.
SPRING DEVELOPMENT FOR MEDICAL DEVICES
EXPERT VIEW
Neil Fletcher
SPRING DEVELOPMENT FOR MEDICAL DEVICES
Neil Fletcher provides a spring manufacturer’s perspective of how springs can be used in medical devices, and how a lengthy and extensive device development process affects normal custom and practice in our industry. The report focuses on spring technology and highlights some of the challenges that spring manufacturers face daily.
SELECTION OF EXCIPIENTS FOR DRY POWDER INHALERS
EXPERT VIEW
Harry Peters
SELECTION OF EXCIPIENTS FOR DRY POWDER INHALERS
Harry Peters and Gerald Hebbink explain how, because dry powder inhalers need a carrier to help with ensuring the drug is effectively delivered, interest has been focused on developing inhalation-grade lactose for this purpose.
LEARNING TO WALK BEFORE WE RUN
EXPERT VIEW
David Harris
LEARNING TO WALK BEFORE WE RUN
David Harris highlights basic problems with inhalers that persist today, and describes why - as the industry looks increasingly towards developing "smart" and connected inhalers - it is important to remember to solve these basic problems.
Top